PD-Rx Pharmaceuticals, Inc. (PDRX)

USD 2.76

(0.0%)

Net Debt Summary of PD-Rx Pharmaceuticals, Inc.

  • PD-Rx Pharmaceuticals, Inc.'s latest annual net debt in 2022 was -6.83 Million USD , down -24.87% from previous year.
  • PD-Rx Pharmaceuticals, Inc.'s latest quarterly net debt in 2022 FY was -6.83 Million USD , down -24.87% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported annual net debt of -5.47 Million USD in 2021, down -88.38% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported annual net debt of -2.9 Million USD in 2020, down -15.14% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported quarterly net debt of -5.47 Million USD for 2021 FY, down -88.38% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported quarterly net debt of -2.9 Million USD for 2020 FY, down -15.14% from previous quarter.

Annual Net Debt Chart of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Historical Annual Net Debt of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Year Net Debt Net Debt Growth
2022 -6.83 Million USD -24.87%
2021 -5.47 Million USD -88.38%
2020 -2.9 Million USD -15.14%
2019 -2.52 Million USD -4.72%
2018 -2.4 Million USD 37.59%
2017 -3.86 Million USD 24.07%
2016 -5.08 Million USD 3.25%
2015 -5.25 Million USD -31.99%
2014 -3.98 Million USD 35.36%
2013 -6.15 Million USD -47.87%
2012 -4.16 Million USD 0.0%

Peer Net Debt Comparison of PD-Rx Pharmaceuticals, Inc.

Name Net Debt Net Debt Difference
China Medicine Corporation 9.03 Million USD 175.639%
DH Enchantment Inc. 409.44 Thousand USD 1768.97%
Exlites Holdings International, Inc. - USD Infinity%
Itonis, Inc. 909.99 Thousand USD 850.937%
One Step Vending Corp. 247.1 Thousand USD 2865.397%
MediPal Holdings Corporation -1.49 Billion USD 99.544%
Pharmagen, Inc. 4362.26 USD 156750.819%
Suzuken Co., Ltd. -1.17 Billion USD 99.419%